At a glance
- Originator Fisons
- Class Antiasthmatics
- Mechanism of Action Leukotriene D4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 20 Aug 1997 No-Development-Reported for Asthma (Unknown route)
- 08 Nov 1994 Investigation in Asthma (Unknown route)